Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-07

Clinical Trial Update: NIRS Neurofeedback as a Treatment for Attention Deficit Hyperactivity Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating near-infrared spectroscopy (NIRS) neurofeedback as a treatment for Attention Deficit Hyperactivity Disorder; the current statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NIRS Neurofeedback

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Attention Deficit Hyperactivity Disorder | Phase 2 | Status: UNKNOWN